★ Sector
Pharma & Biotech Manufacturing
January 2025 – November 2025
- Orgs
- 11
- Actions
- 11
- Topics
- 3
Companies whose primary business is the research, development, and manufacture of prescription drugs, vaccines, and biologic therapies, following the GICS Pharmaceuticals and Biotechnology classification. Narrower than the broader Pharmaceuticals & Healthcare sector, it excludes pharmacy-benefit managers, diagnostics and medical-device makers, distributors, telehealth providers, and healthcare investors.
Organizations
Actions
Actions involving organizations in this sector, players affiliated with them, or sector-wide benefits.
- Eli Lilly pledges $27B in U.S. manufacturing under Trump$27BPrivate ActionNovember 2025
- Trump signs bill delaying Medicare price cuts on top-selling drugsGovernment ActionBeneficiaryJuly 2025
Drug and biotechnology manufacturers benefit from provisions that delay or exempt their top-selling medicines from Medicare price negotiation, preserving billions of dollars in revenue the negotiation program would otherwise have reduced.
- Abbott Laboratories donates $500K to Trump-Vance inaugural$500KPrivate ActionJanuary 2025
- Amgen Inc donates $500K to Trump-Vance inaugural$500KPrivate ActionJanuary 2025
- Bayer Corp donates $1M to Trump-Vance inaugural$1MPrivate ActionJanuary 2025
- Eli Lilly & Co donates $500K to Trump-Vance inaugural$500KPrivate ActionJanuary 2025
- Gilead Sciences donates $1M to Trump-Vance inaugural$1MPrivate ActionJanuary 2025
- Johnson & Johnson donates $1M to Trump-Vance inaugural$1MPrivate ActionJanuary 2025
- Merck, Sharp & Dohme donates $1M to Trump-Vance inaugural$1MPrivate ActionJanuary 2025
- Pfizer Inc donates $1M to Trump-Vance inaugural$1MPrivate ActionJanuary 2025
- Vaxcyte Inc donates $1M to Trump-Vance inaugural$1MPrivate ActionJanuary 2025